Elsevier

Atherosclerosis

Volume 233, Issue 2, April 2014, Pages 410-414
Atherosclerosis

Cardiovascular biomarkers in vertically HIV-infected children without metabolic abnormalities

https://doi.org/10.1016/j.atherosclerosis.2014.01.025Get rights and content

Highlights

  • We compared cardiovascular risk in healthy controls and HIV-infected children.

  • We determined inflammatory, endothelial, and hemostatic biomarkers and IMT.

  • Subjects in our study were on treatment with no metabolic disturbances.

  • No up-regulation of proinflammatory pathways or IMT was found in this cohort.

  • A strict control of metabolic alterations is a must in this special population.

Abstract

Early cardiovascular disease is a major concern for ART-suppressed vertically HIV-infected children; however, evidence is lacking regarding specific preventive measures. In this study, a complete panel of biomarkers was determined together with carotid intima-media thickness (IMT), in a cohort of 64 HIV-infected children and 30 controls. Mean age of participants was 14.1 ± 5 years. HIV-infected patients showed normal lipid profile, with only slightly higher triglycerides, and no differences between groups were found regarding IMT. HIV-infected patients displayed higher levels of soluble CD14 (sCD14) and soluble vascular cell adhesion molecule-1 (sVCAM) (all p < 0.05). However, levels of C-reactive protein, interleukin-6, myeloperoxidase, monocyte chemoattractant protein-1, P-selectin and tissue plasminogen activator were similar between groups. Vertically HIV-infected subjects on ART with no significant metabolic disturbances displayed increased sCD14 and sVCAM but not up-regulation of proinflammatory pathways. Larger studies are warranted to assess the impact of a strict metabolic control on cardiovascular risk and to define specific cardiovascular disease preventive strategies in this population.

Introduction

HIV infection is associated with vascular dysfunction and adverse cardiovascular outcomes, likely driven by up-regulation of inflammatory pathways, accumulation of classical cardiovascular risk factors and ART-related metabolic disturbances [1]. The scope of cardiovascular disease may become even greater in years to come in the special population of vertically HIV-infected subjects, with lifelong exposure to inflammation and metabolic abnormalities. Indeed, previous studies suggest that vertically HIV-infected adolescents already exhibit subclinical atherosclerosis [2], [3], [4].

Although extensively analyzed, the pathophysiology of atherosclerosis within HIV infection remains to be entirely elucidated. HIV-infection is characterized by increased concentrations of proinflammatory cytokines, such as C-reactive protein (CRP) and interleukin (IL)-6, even under viral suppression [5]. Importantly, some of these markers strongly predict cardiovascular disease and mortality [6], [7]. Soluble CD14 (sCD14), a marker of monocyte activation used as an indirect measure of microbial translocation, has been associated to disease progression and mortality, although its relation to endothelial dysfunction remains controversial [8], [9]. Most of the evidence in this field comes from studies performed in adults, and data supporting increased levels of proinflammatory cytokines during childhood are controversial [2], [3], [4], [10], [11].

Unraveling the proatherogenic pathways up-regulated in vertically HIV-infected individuals remains critical in order to design strategies for cardiovascular disease prevention in this particular population. In this scenario, we assessed relations between intima-media thickness (IMT) and proinflammatory cytokines [IL-6, CRP, myeloperoxidase (MPO)], tissue plasminogen activator (tPA), adhesion molecules [Soluble vascular cell adhesion molecule-1 (sVCAM-1), and pSelectine] and sCD14, in a cohort of ART-treated HIV-infected children and adolescents and healthy controls.

Section snippets

Study design and eligibility criteria

We performed a sub-study within an ongoing longitudinal, observational study evaluating cardiovascular risk in HIV-infected children and healthy controls [12]. Participants with available plasma samples were included in this analysis. Exclusion criteria included acute or opportunistic infections, family history of premature CVD, chronic conditions and use of medications other than ART.

The study was reviewed and approved by the Ethics Committee and Clinical Research of the participating

Study population and between group comparison of clinical characteristics

A total of 64 HIV-infected children and adolescents and 30 healthy controls were included, with a mean age of 14.1 ± 5.0 years. Main characteristics of both cohorts are summarized in Table 1.

HIV-infected and uninfected subjects showed similar age, gender, BMI, blood pressure and frequency of hypertension. Of note, there were no significant differences between groups regarding levels of total cholesterol, HDLc or LDLc, and only triglycerides were mildly elevated. Although median IMT was slightly

Discussion

In this study we evaluated carotid atherosclerosis and an extensive panel of biomarkers involved in inflammatory, endothelial, and hemostatic pathways in a cohort of vertically ART-treated HIV-infected subjects and healthy controls. No differences in lipids, BMI, visceral obesity or IMT were found between groups. In this scenario of lack of relevant ART mediated metabolic disorders and good disease control we found similar levels of most biomarkers between both groups, with the exception of

Authors contributions to the work

T. Sainz, study design, data analysis, writing. L. Díaz, laboratory analysis and interpretation. ML. Navarro, recruitment, data collection and analysis Hospital Gregorio Marañón. P. Rojo, recruitment, data collection and analysis Hospital 12 de Octubre. D. Blázquez, recruitment, data collection and analysis Hospital 12 de Octubre. J. Ramos, recruitment, data collection and analysis Hospital de Getafe. M. Alvarez; data collection and analysis S. Serrano-Villar, study design, statistical

Funding

This work was partially supported by a Small Grant Award from the European Society of Pediatric Infectious Diseases (ESPID) and the Fondo para la Investigación Sanitaria (FIS grant: PI12/01483) of the Spanish Ministry of Science and Innovation. Philips Healthcare kindly provided portable ultrasound equipment for the purpose of the study. T.S. and S.S-V are funded by grants from the Spanish Ministry of Science and Innovation (Ayudas para Contratos de Formación en Investigación Río Hortega). L.D.

Acknowledgments

The authors would like to particularly acknowledge all the children and adolescents as well as their families for their participation in this study. The authors would like to thank all the professionals involved, and particularly the ones integrating the Pediatric branch of the National AIDS Research Network of Spain (CORISPE). We acknowledge the Paediatric HIV-BioBank integrated in the Spanish AIDS Research Network and collaborating Centers, supported by the Instituto de Salud Carlos III,

References (20)

  • A.C. Ross et al.

    Heightened inflammation is linked to carotid intima-media thickness and endothelial activation in HIV-infected children

    Atherosclerosis

    (2010)
  • P.Y. Hsue et al.

    Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis

    AIDS

    (2009)
  • M. Charakida et al.

    Early structural and functional changes of the vasculature in HIV-infected children: impact of disease and antiretroviral therapy

    Circulation

    (2005)
  • G.A. McComsey et al.

    Increased carotid intima media thickness and cardiac biomarkers in HIV infected children

    AIDS

    (2007)
  • J. Neuhaus et al.

    Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection

    J Infect Dis

    (2010)
  • V.A. Triant et al.

    Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease

    J Clin Endocrinol Metab

    (2007)
  • S. Ferrando-Martinez et al.

    Thymic function failure and C-reactive protein levels are independent predictors of all-cause mortality in healthy elderly humans

    Age (Dordr)

    (2013 Feb)
  • N.G. Sandler et al.

    Plasma levels of soluble CD14 independently predict mortality in HIV infection

    J Infect Dis

    (2011)
  • C. Longenecker et al.

    Markers of inflammation and CD8 T-cell activation, but not monocyte activation, are associated with subclinical carotid artery disease in HIV-infected individuals

    HIV Med

    (2013)
  • T.L. Miller et al.

    Biomarkers of vascular dysfunction in children infected with human immunodeficiency virus-1

    J Acquir Immune Defic Syndr

    (2010)
There are more references available in the full text version of this article.

Cited by (18)

  • The effect of perinatal HIV and antiretroviral therapy on vascular structure and function in young people: A systematic review and meta-analysis

    2022, Atherosclerosis
    Citation Excerpt :

    Deranged lipids profile increases atherogenesis and vascular damage, consequently increasing the risk of cardiovascular disease [54]. Although there is evidence that some antiretroviral agents have metabolic side effects including dyslipidaemia which increases cardiovascular risk [55], it is also plausible that suppression of HIV viraemia with ART can slow down the progression of vascular damage - perhaps explaining why some vascular markers were similar between those who were receiving ART and uninfected controls [26,27,46,33,40]. There is evidence pointing to an association of PI-based regimens with vascular dysfunction as well as reports of improvements in vascular markers, particularly endothelial function following ART-initiation, regardless of ART-regimen [56].

  • Alcohol use is associated with mental health problems and brain structural alterations in adolescents with perinatally acquired HIV infection on ART

    2021, Alcohol
    Citation Excerpt :

    CTAAC has demonstrated that CNS disease (Hoare et al., 2018), mental health problems (Hoare, Phillips, et al., 2019) and substance use (Brittain et al., 2019) persist in South African PHIV despite ART and viral suppression, contributing to a significant decline in functioning (Phillips et al., 2018) Self-reported alcohol use in PHIV from the CTAAC parent study increased from 8% at the baseline visit to 21% at 36 month follow-up visit (Brittain et al., 2019). In adolescents with PHIV, the relationship of alcohol use to inflammatory markers has not yet been studied, though studies in PHIV have found that neopterin and sCD14 levels are elevated (Blokhuis et al., 2019; Sainz et al., 2014; Syed et al., 2013)and that CRP, and IL-6 are associated with decreased processing speed in PHIV(Kapetanovic, Aaron, Montepiedra, Burchett, & Kovacs, 2012). We have recently reported that among PHIV with a neurocognitive disorder, hs-CRP negatively correlated with general intelligence, visual spatial acuity and executive function and whole brain MD correlated with higher hs-CRP values (Jacqueline et al., 2020).

  • Lower total and regional grey matter brain volumes in youth with perinatally-acquired HIV infection: Associations with HIV disease severity, substance use, and cognition

    2017, Brain, Behavior, and Immunity
    Citation Excerpt :

    Proton magnetic resonance spectroscopy studies (MRS) have found that in adult HIV patients, elevated neurofilament light chain in the cerebrospinal fluid correlated with MRS abnormalities in the anterior cingulate, frontal white matter, and parietal grey matter (Peluso et al., 2013). In youth with PHIV, the relationship of brain volumes to inflammatory markers has not yet been studied, though studies in youth with PHIV have found that neopterin and sCD14 levels are elevated (Blokhuis et al., 2016; Sainz et al., 2014; Syed et al., 2013) and that aggregate measures of fibrinogen, CRP, and IL-6 are associated with decreased processing speed in youth with PHIV and in uninfected youth with perinatal HIV exposure (Kapetanovic et al., 2014). Future studies should aim to assess effects of PHIV, cART, and substance use with longitudinal neuroimaging and include diverse measures of HIV disease severity and inflammation, which may provide more information on when the brain is most vulnerable to HIV and substance use, as well as when treatment is most effective.

  • Is the atherosclerotic process accentuated under conditions of HIV infection, antiretroviral therapy, and protease inhibitor exposure? Meta-analysis of the markers of arterial structure and function

    2015, Atherosclerosis
    Citation Excerpt :

    Applying the search strategy, 3205 papers were found. Overall, 57 studies were included in this meta-analysis (Fig. 1), of which 56 were full text and one was a conference paper providing detailed information [8–10,13–66]. The characteristics of the selected studies are listed in Tables S1–S3.

View all citing articles on Scopus
View full text